These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3158659)

  • 1. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ; Sandhoff K
    J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of domains in human beta-hexosaminidase that determine substrate specificity.
    Pennybacker M; Liessem B; Moczall H; Tifft CJ; Sandhoff K; Proia RL
    J Biol Chem; 1996 Jul; 271(29):17377-82. PubMed ID: 8663217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
    Burg J; Banerjee A; Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
    Hechtman P; Kachra Z
    Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
    Meier EM; Schwarzmann G; Fürst W; Sandhoff K
    J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
    Sharma R; Bukovac S; Callahan J; Mahuran D
    Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.
    Hou Y; Tse R; Mahuran DJ
    Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.
    Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D
    J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.